Korean J Intern Med.  2014 Jan;29(1):96-100. 10.3904/kjim.2014.29.1.96.

Duodenal adenocarcinoma following a neuroendocrine tumor in the duodenum

Affiliations
  • 1Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. swoopark@yuhs.ac
  • 2Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
  • 3Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Primary duodenal adenocarcinoma is a rare malignant neoplasm accounting for 0.3% of all gastrointestinal tract carcinomas. We herein present one case of duodenal adenocarcinoma after duodenal neuroendocrine carcinoma. Poorly differentiated duodenal neuroendocrine carcinoma with liver metastasis (TxNxM1) was confirmed, and eight cycles of palliative chemotherapy (5-fluorouracil/etoposide/cisplatin) were administered. The patient was then in a clinically complete response status. About 1 year later, newly developed adenocarcinoma was detected at the same site. It was completely surgically resected, and the patient was cured.

Keyword

Neuroendocrine tumors; Duodenal neoplasms; Drug therapy

MeSH Terms

Adenocarcinoma/*diagnosis/drug therapy
Antineoplastic Agents/therapeutic use
Duodenal Neoplasms/*diagnosis/drug therapy
Humans
Male
Middle Aged
Neoplasms, Second Primary/*diagnosis/drug therapy
Neuroendocrine Tumors/*diagnosis/drug therapy
Antineoplastic Agents
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr